West Jefferson Medical Center Joins Growing Group of Imaging Centers Installing SoftVue Breast Ultrasound Tomography
30 Julio 2024 - 6:05AM
Business Wire
Center’s Chief Nursing Officer Monica Bologna,
MSN, RN, CENP says new breast imaging system fills a screening gap
for women with dense breasts in the Louisiana region
Delphinus Medical Technologies, today announced the latest
installation of its breakthrough dense breast imaging technology
SoftVue™ Breast Ultrasound Tomography (UST) at West Jefferson
Medical Center in Louisiana.
“The launch of West Jefferson Medical Center’s SoftVue Dense
Breast Screening Program demonstrates the expanding adoption of
SoftVue across the country. West Jefferson joins a growing group of
progressive health centers investing in Delphinus’s advanced breast
ultrasound tomography as an adjunct to mammography, to better serve
the 50 percent of women with dense breasts screened annually,”
said Scott White, CEO of Delphinus Medical Technologies.
“The proactive approach taken by the West Jefferson Medical Center
team to improve patient outcomes for women with dense breasts is in
lock step with our mission to enable the early detection of breast
cancer.”
SoftVue UST is the only imaging modality designed specifically
to find more cancer in women with dense breasts and is also the
only ultrasound-based breast imaging system that is FDA-approved
for same-day screening as mammography. Delphinus designed the
system as an adjunct to mammography for women with dense breasts to
address the fact that breast cancer screening with mammography
alone reduces mortality by 41% in women with non-dense breasts but
reduces mortality by only 13% in women with dense breasts.
“We recognize that women with dense breasts need screening in
addition to mammograms, as cancers can hide in dense breast tissue
on X-ray, but until now our breast center lacked an efficient and
effective modality,” said Monica Bologna, MSN, RN, CENP, chief
nursing officer at West Jefferson Medical Center – LCMC Health.
“SoftVue offers a screening solution for this patient population
that not only increases cancer detection, but also improves our
workflow and the patient experience which is what has been missing
in our breast center.”
When combined with mammography, SoftVue increases sensitivity by
20 percent and specificity by eight percent, offering comprehensive
characterization at the point of screening which helps increase
cancer detection and reduce short-term follow-ups. In addition,
SoftVue can be performed during the same visit as the women’s
mammogram, saving patients time and improving the diagnostic
clinical workflow for a bustling breast center.
About Delphinus Medical Technologies, Inc.
Headquartered in Novi, Mich., Delphinus Medical Technologies,
Inc. is a pioneering medical imaging company that developed
SoftVue™, featuring the first circular array transducer technology.
The patented technology is a 3D whole-breast ultrasound tomography
system that delivers no radiation, requires no compression, and
images the entire breast with a single scan. To learn more, visit
our website and follow us on LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240730252734/en/
Sam Choinski Pazanga Health Communications
schoinski@pazangahealth.com (860) 301-5058